UNSPSC 51101922: Artenimol

This classification denotes an antimalarial agent with the molecular formula C15H24O5, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 6A9O50735X, chemically known as (3r,5as,6r,8as,9r,10s,12r,12ar)-decahydro-3,6,9-trimethyl-3,12-epoxy-12h-pyrano(4,3,-j)-1,2-benzodioxepin-10-ol but generally known as artenimol, which bears US NIH Compound Identifier 179336. European Medicines Agency schedules Artenimol in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB30709.

UNSPSC 51101922 Artenimol, a Commodity code, nominally covers a specific antimalarial drug, but recent state and local opportunities tagged under this code show little alignment with the code's nominal scope. The Illinois Department of Public Health awarded a $2,999,999.11 pharmaceutical warehouse piggyback contract through MMCAP Infuse to Chartwell Rx LLC on August 28, 2026, for supply of Doxycycline Hyclate 100mg tablets and Ciprofloxacin Hydrochloride 500mg tablets — broad-spectrum antibiotics unrelated to artenimol. Seminole County, Florida posted an IFB on June 30, 2026, for 1,900 units of Naloxone and 800 Safe Drug Deactivation Systems annually, also unrelated to the code's stated product. The mismatch between the code's nominal scope and the actual procurement activity suggests either systematic miscoding by state and local procurement offices or a data-alignment issue. State and local governments appear to be using this commodity code for general pharmaceutical warehouse and emergency medical supply contracts rather than for artenimol specifically.

The Illinois procurement was completed through a consortium vehicle (MMCAP Infuse) with an IFB process and a 12-month initial term plus two renewal options. The Seminole County opportunity, posted with a July 26, 2023 response date, required quarterly deliveries to a county health building with vendor-paid shipping and compliance with E-Verify and drug-free workplace requirements. No set-aside designations were identified in either opportunity. Geographic activity is limited to Illinois and Florida in the recent record. Given the minimal alignment between the code's nominal scope and actual state and local purchasing activity, and the absence of open solicitations currently seeking artenimol, this code shows little relevant recent activity for pursuit.